Relign Corporation, Subsidiary Of Zimmer Biomet

FDA Regulatory Profile

Relign Corporation, Subsidiary Of Zimmer Biomet appears in FDA public data with 0 recalls, 1 510(k) clearance, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on May 8, 2024.

Reviewing Relign Corporation, Subsidiary Of Zimmer Biomet as a supplier? Get its full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.

Get a free API key

Summary

Total Recalls
0
510(k) Clearances
1
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K241008Tricera Arthroscopic System; Tricera Controller (R-10001); Tricera Handpiece, Autoclavable (R-10023May 8, 2024